Rafael Gafoor

894 total citations
22 papers, 472 citations indexed

About

Rafael Gafoor is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Rafael Gafoor has authored 22 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 8 papers in Clinical Psychology and 4 papers in Pharmacology. Recurrent topics in Rafael Gafoor's work include Schizophrenia research and treatment (11 papers), Bipolar Disorder and Treatment (3 papers) and Treatment of Major Depression (3 papers). Rafael Gafoor is often cited by papers focused on Schizophrenia research and treatment (11 papers), Bipolar Disorder and Treatment (3 papers) and Treatment of Major Depression (3 papers). Rafael Gafoor collaborates with scholars based in United Kingdom, Zambia and Chile. Rafael Gafoor's co-authors include Martin Gulliford, Helen Booth, Philip McGuire, Paddy Power, Lucia Valmaggia, James B. Woolley, Elvira Bramon, Louise Johns, P. Tabraham and Matthew R. Broome and has published in prestigious journals such as PLoS ONE, The British Journal of Psychiatry and BMJ.

In The Last Decade

Rafael Gafoor

21 papers receiving 451 citations

Peers

Rafael Gafoor
Pietro Calcagno Italy
Lebogang Phahladira South Africa
Paul D. Meesters Netherlands
B. Auestad Norway
Michael D. Teehan Canada
Christoph U. Correll United States
Corrine Cather United States
Minna Torniainen Finland
Cris Henderson United States
F. Abalan France
Pietro Calcagno Italy
Rafael Gafoor
Citations per year, relative to Rafael Gafoor Rafael Gafoor (= 1×) peers Pietro Calcagno

Countries citing papers authored by Rafael Gafoor

Since Specialization
Citations

This map shows the geographic impact of Rafael Gafoor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Gafoor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Gafoor more than expected).

Fields of papers citing papers by Rafael Gafoor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Gafoor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Gafoor. The network helps show where Rafael Gafoor may publish in the future.

Co-authorship network of co-authors of Rafael Gafoor

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Gafoor. A scholar is included among the top collaborators of Rafael Gafoor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Gafoor. Rafael Gafoor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gomes, Manuel, et al.. (2024). Measuring quality of life of adults with intellectual disabilities: Psychometric evaluation of the personal outcomes scale in the United Kingdom. Journal of Applied Research in Intellectual Disabilities. 37(2). e13189–e13189. 1 indexed citations
2.
Gafoor, Rafael, Nicola Morant, Nicola Dalrymple, et al.. (2024). Cognitive Behaviour Therapy for Depersonalisation Derealisation Disorder (CBT-f-DDD): Study protocol for a randomised controlled feasibility trial. PLoS ONE. 19(8). e0307191–e0307191.
3.
4.
5.
Gillard, Julia, Livia Ottisova, E. Walsh, et al.. (2022). The effectiveness of trauma-focused psychotherapy for complex post-traumatic stress disorder: A retrospective study. European Psychiatry. 66(1). e4–e4. 10 indexed citations
6.
Lamb, Danielle, Neil Greenberg, Matthew Hotopf, et al.. (2021). NHS CHECK: protocol for a cohort study investigating the psychosocial impact of the COVID-19 pandemic on healthcare workers. BMJ Open. 11(6). e051687–e051687. 11 indexed citations
7.
Gafoor, Rafael, Judith Charlton, Rathi Ravindrarajah, & Martin Gulliford. (2019). Importance of Frailty for Association of Antipsychotic Drug Use With Risk of Fracture: Cohort Study Using Electronic Health Records. Journal of the American Medical Directors Association. 20(12). 1495–1501.e1. 6 indexed citations
8.
Gafoor, Rafael, Helen Booth, & Martin Gulliford. (2018). Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: population based cohort study. BMJ. 361. k1951–k1951. 123 indexed citations
9.
Gafoor, Rafael, et al.. (2010). Esquire Trial. Journal of Clinical Psychopharmacology. 30(5). 600–606. 14 indexed citations
10.
Gafoor, Rafael, Dorothea Nitsch, Paul McCrone, et al.. (2010). Effect of early intervention on 5-year outcome in non-affective psychosis. The British Journal of Psychiatry. 196(5). 372–376. 97 indexed citations
11.
Gafoor, Rafael, Tom Craig, Philippa Garety, Paddy Power, & Philip McGuire. (2009). Do the Benefits of Early Intervention (EI) Treatments for Schizophrenia Persist?. European Psychiatry. 24(S1). 3 indexed citations
12.
Gafoor, Rafael, Tom Craig, Philippa Garety, Paddy Power, & Philip McGuire. (2008). 121 – Do the benefits of early intervention (EI) treatments for schizophrenia persist? 5-year follow-up. Schizophrenia Research. 98. 83–83. 3 indexed citations
13.
Gafoor, Rafael, Thelma Craig, Paddy Power, R Kerwin, & Philip McGuire. (2006). FC4A 12 WEEK RANDOMISED BLINDED TRIAL OF QUETIAPINE VERSUS RISPERIDONE: RELATIVE ANTIPSYCHOTIC EFFICACIES AND SIDE EFFECTS. Schizophrenia Research. 86. S38–S38. 1 indexed citations
14.
Forti, Marta Di, Arthur M. Butt, Rafael Gafoor, et al.. (2006). Does age at first use predict length and frequency of cannabis use. Research Portal (King's College London). 81. 233–233. 1 indexed citations
15.
Gafoor, Rafael, et al.. (2005). A comparative study of quetiapine and risperidone in patients with first-episode psychosis. European Neuropsychopharmacology. 15. 4 indexed citations
16.
Broome, Matthew R., James B. Woolley, Louise Johns, et al.. (2005). Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state. European Psychiatry. 20(5-6). 372–378. 143 indexed citations
17.
Gafoor, Rafael, et al.. (2005). Equiefficacy of quetiapine versus risperidone in the treatment of depression in patients in their first episode of a schizophreniform psychotic illness: Interim results of an 8 week randomised single blind trial. Research Portal (King's College London). 31(2). 483–484. 2 indexed citations
18.
Gafoor, Rafael & Veronica O’Keane. (2003). Three case reports of secondary mania: evidence supporting a right frontotemporal locus. European Psychiatry. 18(1). 32–33. 19 indexed citations
19.
Gafoor, Rafael, et al.. (2003). Three case reports of emergent dyskinesia with clozapine. European Psychiatry. 18(5). 260–261. 6 indexed citations
20.
Ramsbottom, Dorothy, et al.. (1997). The cholesteryl ester transfer protein (CETP) locus as a candidate gene in abdominal aortic aneurysm. Clinical Genetics. 51(4). 241–245. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pietro Calcagno Breakdown of academic impact, for papers by Lebogang Phahladira Breakdown of academic impact, for papers by Paul D. Meesters Breakdown of academic impact, for papers by B. Auestad Breakdown of academic impact, for papers by Michael D. Teehan Breakdown of academic impact, for papers by Christoph U. Correll Breakdown of academic impact, for papers by Corrine Cather Breakdown of academic impact, for papers by Minna Torniainen Breakdown of academic impact, for papers by Cris Henderson Breakdown of academic impact, for papers by F. Abalan
Rankless by CCL
2026